Bidding 11-13 Dec 2024, price band ₹522–549, lot 27 shares.
GMP last updated: 2 Apr 2026, 8:37 AM IST
| Date | GMP (₹) | Est. Listing Price (₹) | Est. Listing Gain |
|---|---|---|---|
| 4 Oct | ₹11 | ₹560 | 2.00% |
| 3 Oct | ₹32 | ₹581 | 5.83% |
| 2 Oct | ₹17 | ₹566 | 3.10% |
| 1 Oct | ₹10 | ₹559 | 1.82% |
| 30 Sep | ₹8 | ₹557 | 1.46% |
After allotment
| Category | Times | Est. Allotment Chances* |
|---|---|---|
| HNIs (Total) | 2.45 | 40.8% |
| bHNI | 3.56 | 28.1% |
| sHNI | 0.24 | 100% |
| QIBs | 1.73 | - |
| Retail | 0.12 | 100% |
| Total | 1.08 | - |
*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.
Sai Life Sciences Limited, established in 1999, is a contract research, development, and manufacturing organization (CRDMO) providing services in drug discovery, development, and manufacturing. The company offers capabilities in chemistry, manufacturing, and control (CMC) and contract research (CRO) for small-molecule new chemical entities. It serves over 280 pharmaceutical companies and operates globally, with facilities in the US, UK, and India. The company employs over 2,300 scientific staff and has received multiple regulatory approvals from authorities including the USFDA and CDSCO.